Standard of care (N = 3) | Unfractionated heparin (N = 4) | |
---|---|---|
Age (years) | 32 ± 18.52 | 29.25 ± 3.77 |
25 (18, 53) | 29 (26, 33) | |
Sex | ||
Male | 1 (33%) | 2 (50%) |
Female | 2 (67%) | 2 (50%) |
Race | ||
African American | 3 (100%) | 4 (100%) |
Genotype | ||
HbSS | 1 (33%) | 2 (50%) |
HbSC | 1 (33%) | 2 (50%) |
HbSβ0 | 1 (33%) | 0 (0%) |
Prior episode of ACS | 3 (100%) | 4 (100%) |
Current hydroxyurea use | 3 (100%) | 4 (100%) |
History of VTE | 0 (0%) | 0 (0%) |
History of myocardial infarction | 0 (0%) | 0 (0%) |
Chronic lung disease | 0 (0%) | 0 (0%) |
History of stroke | 0 (0%) | 0 (0%) |
Active tobacco use | 2 (67%) | 1 (25%) |